VNDA
Vanda Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.43
+1.69%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-10.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 8, 2026 | Mitchell Stephen Ray · director | A-Award | 41,600 | $0.00 |
| Jun 8, 2026 | Duncan Charles Cliff · director | A-Award | 41,600 | $0.00 |
| Jun 8, 2026 | DUGAN RICHARD W · director | A-Award | 41,600 | $0.00 |
| Jun 8, 2026 | McGuire Daniel Patrick · officer: SVP, GC and Secretary | A-Award | 80,000 | $0.00 |
| Jun 8, 2026 | Chrousos Phaedra · director | A-Award | 41,600 | $0.00 |
| Jun 8, 2026 | Ward Anne Sempowski · director | A-Award | 41,600 | $0.00 |
| Jun 8, 2026 | Honore Tage · director | A-Award | 41,600 | $0.00 |
| Apr 24, 2026 | Duncan Charles Cliff · director | A-Award | 57,101 | $0.00 |
| Mar 4, 2026 | Williams Timothy · officer: SVP & General Counsel | Sale | 42,434 | $8.27 |
| Mar 4, 2026 | Polymeropoulos Mihael Hristos · director, officer, other: President and CEO | Sale | 156,235 | $8.17 |
| Mar 4, 2026 | Moran Kevin Patrick · officer: SVP, CFO & Treasurer | Sale | 42,442 | $8.27 |
| Mar 4, 2026 | Birznieks Gunther · officer: SVP, Business Development | Sale | 42,431 | $8.27 |
| Mar 4, 2026 | Wijkstrom Joakim · officer: SVP, Chief Marketing Officer | Sale | 30,800 | $8.27 |
| Feb 24, 2026 | Honore Tage · director | Sale | 30,000 | $8.03 |
| Feb 19, 2026 | Wijkstrom Joakim · officer: SVP, Chief Marketing Officer | A-Award | 125,000 | $0.00 |
| Feb 19, 2026 | Moran Kevin Patrick · officer: SVP, CFO & Treasurer | A-Award | 125,000 | $0.00 |
| Feb 19, 2026 | Williams Timothy · officer: SVP & General Counsel | A-Award | 125,000 | $0.00 |
| Feb 19, 2026 | Birznieks Gunther · officer: SVP, Business Development | A-Award | 125,000 | $0.00 |
| Feb 19, 2026 | Polymeropoulos Mihael Hristos · director, officer, other: President and CEO | A-Award | 525,000 | $0.00 |
| Aug 8, 2025 | Polymeropoulos Mihael Hristos · director, officer, other: President and CEO | Purchase | 10,000 | $4.15 |
| Jun 16, 2025 | Mitchell Stephen Ray · director | Sale | 7,000 | $4.59 |
| Jun 9, 2025 | Mitchell Stephen Ray · director | A-Award | 59,225 | $0.00 |
| Jun 9, 2025 | Ward Anne Sempowski · director | A-Award | 59,225 | $0.00 |
| Jun 9, 2025 | Honore Tage · director | A-Award | 59,225 | $0.00 |
| Jun 9, 2025 | DUGAN RICHARD W · director | A-Award | 59,225 | $0.00 |
| Jun 9, 2025 | Chrousos Phaedra · director | A-Award | 59,225 | $0.00 |
| May 21, 2025 | Polymeropoulos Mihael Hristos · director, officer, other: President and CEO | Purchase | 9,519 | $4.40 |
| May 21, 2025 | Polymeropoulos Mihael Hristos · director, officer, other: President and CEO | Purchase | 481 | $4.39 |
| May 19, 2025 | Polymeropoulos Mihael Hristos · director, officer, other: President and CEO | Purchase | 20,000 | $4.22 |
| Mar 6, 2025 | Polymeropoulos Mihael Hristos · director, officer, other: President and CEO | Purchase | 5,000 | $5.01 |
Institutional positioning
13F filings over the trailing two quarters
New 77Increased 132Reduced 96Sold out 25
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 7,653,737 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 7,275,988 | May 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 3,759,559 | May 14, 2026 |
| STATE STREET CORP | Increased | 3,516,405 | Aug 7, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 3,497,695 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 3,441,361 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 3,015,562 | May 15, 2026 |
| AIGH CAPITAL MANAGEMENT LLC | Increased | 2,750,000 | Apr 30, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,524,040 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,481,491 | May 15, 2026 |
| AIGH Capital Management LLC | Reduced | 2,044,169 | Aug 7, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,918,063 | Aug 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 1,881,001 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 1,795,592 | May 13, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 1,771,593 | May 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 8, 2026